Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1.23B
-
Number of holders
-
454
-
Total 13F shares, excl. options
-
250M
-
Shares change
-
+566K
-
Total reported value, excl. options
-
$11.3B
-
Value change
-
+$51.2M
-
Put/Call ratio
-
0.97
-
Number of buys
-
194
-
Number of sells
-
-209
-
Price
-
$45.25
Significant Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q1 2017
540 filings reported holding SNY - Sanofi - Common Stock and American Depositary Receipts as of Q1 2017.
Sanofi - Common Stock and American Depositary Receipts (SNY) has 454 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 250M shares
of 1.23B outstanding shares and own 20.38% of the company stock.
Largest 10 shareholders include DODGE & COX (68M shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (29.4M shares), FRANKLIN RESOURCES INC (21M shares), Fisher Asset Management, LLC (12.6M shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (10.4M shares), Boston Partners (8.53M shares), Invesco Ltd. (8.3M shares), BANK OF AMERICA CORP /DE/ (7.53M shares), FMR LLC (5.22M shares), and FEDERATED INVESTORS INC /PA/ (5.12M shares).
This table shows the top 454 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.